GLP3 · 30 mg
Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.
$169.00$249.00
Metabolic Research
Tesamorelin 20 mg
$170.00$249.0098.9% purity · Batch Tesa-260610
Growth hormone-releasing factor analogue in a 20 mg batch-coded vial for metabolic and body-composition research.
Lot analysis published for this batch. Independent Janoshik Analytical testing (Jun 2026) — purity, content and endotoxin, shown unedited further down this page.1
- Third-party HPLC & mass-spec verified
- Same-day dispatch before 2 PM ET
- Cold-packed, tamper-sealed shipping
- Batch-coded and dated at fill
Research background
The 20 mg presentation of our tesamorelin research peptide — a synthetic analogue of human growth hormone-releasing factor investigated in metabolic pathway and adipose-tissue research. Sealed, lot-coded and supplied with the published third-party lot report for the batch printed on the label.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Lot analysis for this batch
- Lot
- Tesa-260610
- Purity (3 vials)
- 99.04 / 98.81 / 98.82 %
- Content (3 vials)
- 22.21 / 21.16 / 21.15 mg
- Endotoxin
- 6.123 EU/vial
- Tested by
- Janoshik Analytical, Jun 2026
Published in full and unedited — verify it with the key printed on the report.
Specifications
- Molecular formula
- C221H366N72O67S
- Molar mass
- 5135.9 g/mol
- Form
- Lyophilised white powder
- Storage
- -20 °C, protect from light
- Certificate of analysis
- View batch Tesa-260610
More in Metabolic Research
GLP2 · 30 mg
Dual GIP/GLP-1 receptor research peptide in a 30 mg batch-coded vial, with its lot report published in full.
$89.00$139.00
Tesamorelin · 10 mg
Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.
$95.00$169.00
Tesamorelin 20 mg
$170.00